FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2016738587> ?p ?o ?g. }

• W2016738587 endingPage "1233" @default.
• W2016738587 startingPage "1218" @default.
• W2016738587 abstract "Background Patients with Estrogen Receptor α‐positive (ER+) Inflammatory Breast Cancer (IBC) are less responsive to endocrine therapy compared with ER+ non‐IBC (nIBC) patients. The study of ER+ IBC samples might reveal biomarkers for endocrine resistant breast cancer. Materials & methods Gene expression profiles of ER+ samples from 201 patients were explored for genes that discriminated between IBC and nIBC. Classifier genes were applied onto clinically annotated expression data from 947 patients with ER+ breast cancer and validated with RT‐qPCR for 231 patients treated with first‐line tamoxifen. Relationships with metastasis‐free survival (MFS) and progression‐free survival (PFS) following adjuvant and first‐line endocrine treatment, respectively, were investigated using Cox regression analysis. Results A metagene of six genes including the genes encoding for 4‐aminobutyrate aminotransferase (ABAT) and Stanniocalcin‐2 (STC2) were identified to distinguish 22 ER+ IBC from 43 ER+ nIBC patients and remained discriminatory in an independent series of 136 patients. The metagene and two genes were not prognostic in 517 (neo)adjuvant untreated lymph node‐negative ER+ nIBC breast cancer patients. Only ABAT was related to outcome in 250 patients treated with adjuvant tamoxifen. Three independent series of in total 411 patients with advanced disease showed increased metagene scores and decreased expression of ABAT and STC2 to be correlated with poor first‐line endocrine therapy outcome. The biomarkers remained predictive for first‐line tamoxifen treatment outcome in multivariate analysis including traditional factors or published signatures. In an exploratory analysis, ABAT and STC2 protein expression levels had no relation with PFS after first‐line tamoxifen. Conclusions This study utilized ER+ IBC to identify a metagene including ABAT and STC2 as predictive biomarkers for endocrine therapy resistance." @default.
• W2016738587 created "2016-06-24" @default.
• W2016738587 creator A5004737640 @default.
• W2016738587 creator A5006499239 @default.
• W2016738587 creator A5007235093 @default.
• W2016738587 creator A5022173747 @default.
• W2016738587 creator A5030195934 @default.
• W2016738587 creator A5032131062 @default.
• W2016738587 creator A5040594661 @default.
• W2016738587 creator A5041093711 @default.
• W2016738587 creator A5041555565 @default.
• W2016738587 creator A5043655122 @default.
• W2016738587 creator A5056586350 @default.
• W2016738587 creator A5062913819 @default.
• W2016738587 creator A5063917865 @default.
• W2016738587 creator A5065210354 @default.
• W2016738587 creator A5066680524 @default.
• W2016738587 creator A5066926133 @default.
• W2016738587 creator A5071056994 @default.
• W2016738587 creator A5077531941 @default.
• W2016738587 creator A5084660376 @default.
• W2016738587 creator A5085490585 @default.
• W2016738587 creator A5090100329 @default.
• W2016738587 creator A5090190690 @default.
• W2016738587 creator A5091721810 @default.
• W2016738587 date "2015-03-04" @default.
• W2016738587 modified "2023-10-16" @default.
• W2016738587 title "Decreased expression of ABAT and STC2 hallmarks ER-positive inflammatory breast cancer and endocrine therapy resistance in advanced disease" @default.
• W2016738587 cites W1545202350 @default.
• W2016738587 cites W1961026612 @default.
• W2016738587 cites W1980188722 @default.
• W2016738587 cites W1980970062 @default.
• W2016738587 cites W1995679782 @default.
• W2016738587 cites W2000574364 @default.
• W2016738587 cites W2002861814 @default.
• W2016738587 cites W2009966740 @default.
• W2016738587 cites W2032968026 @default.
• W2016738587 cites W2062071674 @default.
• W2016738587 cites W2072816950 @default.
• W2016738587 cites W2074465378 @default.
• W2016738587 cites W2081562657 @default.
• W2016738587 cites W2085377730 @default.
• W2016738587 cites W2088160256 @default.
• W2016738587 cites W2094130834 @default.
• W2016738587 cites W2096694106 @default.
• W2016738587 cites W2105882193 @default.
• W2016738587 cites W2107061183 @default.
• W2016738587 cites W2107311126 @default.
• W2016738587 cites W2107333022 @default.
• W2016738587 cites W2113334910 @default.
• W2016738587 cites W2118069309 @default.
• W2016738587 cites W2122673439 @default.
• W2016738587 cites W2130639106 @default.
• W2016738587 cites W2130690901 @default.
• W2016738587 cites W2131728143 @default.
• W2016738587 cites W2138550913 @default.
• W2016738587 cites W2139522545 @default.
• W2016738587 cites W2141646633 @default.
• W2016738587 cites W2142188698 @default.
• W2016738587 cites W2143185770 @default.
• W2016738587 cites W2143283599 @default.
• W2016738587 cites W2150249641 @default.
• W2016738587 cites W2150671673 @default.
• W2016738587 cites W2151848392 @default.
• W2016738587 cites W2154467144 @default.
• W2016738587 cites W2157168213 @default.
• W2016738587 cites W2160679814 @default.
• W2016738587 cites W2163563958 @default.
• W2016738587 cites W2168760093 @default.
• W2016738587 cites W2170105757 @default.
• W2016738587 cites W2172012098 @default.
• W2016738587 doi "https://doi.org/10.1016/j.molonc.2015.02.006" @default.
• W2016738587 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5528763" @default.
• W2016738587 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25771305" @default.
• W2016738587 hasPublicationYear "2015" @default.
• W2016738587 type Work @default.
• W2016738587 sameAs 2016738587 @default.
• W2016738587 citedByCount "44" @default.
• W2016738587 countsByYear W20167385872015 @default.
• W2016738587 countsByYear W20167385872016 @default.
• W2016738587 countsByYear W20167385872017 @default.
• W2016738587 countsByYear W20167385872018 @default.
• W2016738587 countsByYear W20167385872019 @default.
• W2016738587 countsByYear W20167385872020 @default.
• W2016738587 countsByYear W20167385872021 @default.
• W2016738587 countsByYear W20167385872022 @default.
• W2016738587 countsByYear W20167385872023 @default.
• W2016738587 crossrefType "journal-article" @default.
• W2016738587 hasAuthorship W2016738587A5004737640 @default.
• W2016738587 hasAuthorship W2016738587A5006499239 @default.
• W2016738587 hasAuthorship W2016738587A5007235093 @default.
• W2016738587 hasAuthorship W2016738587A5022173747 @default.
• W2016738587 hasAuthorship W2016738587A5030195934 @default.
• W2016738587 hasAuthorship W2016738587A5032131062 @default.
• W2016738587 hasAuthorship W2016738587A5040594661 @default.
• W2016738587 hasAuthorship W2016738587A5041093711 @default.
• W2016738587 hasAuthorship W2016738587A5041555565 @default.
• W2016738587 hasAuthorship W2016738587A5043655122 @default.

• next